Headline
The latest stories from AHA Today.
The Centers for Medicare & Medicaid Services yesterday announced additional proposed changes to Medicare Advantage and Part D payment policies for calendar year 2019.
Hospitals are experiencing shortages of sterile water used to reconstitute certain medications for injection.
The Drug Enforcement Administration will focus over the next 45 days on pharmacies and prescribers who are dispensing “unusual or disproportionate amounts” of prescription opioid drugs.
Beginning in October, the Centers for Medicare & Medicaid Services will return both the Health Insurance Claim Number and Medicare beneficiary identifier on the remittance advice when a provider submits a claim.
The AHA, along with Baxter International Foundation and the Health Research & Educational Trust, is accepting applications through April 6 for the 2018 Foster G. McGaw Prize.
The report recommends VA develop a strategic plan to enhance and facilitate timely access to patient-centered care, hire and retain diverse skilled staff, and more.
The Centers for Medicare & Medicaid Services has extended the Medicaid demonstration waiver for the Healthy Indiana Plan through February while it continues to review the state’s new waiver application.
In his state of the union address last night, President Trump said reducing prescription drug prices is “one of my greatest priorities.”
Centers for Disease Control and Prevention Director Brenda Fitzgerald, M.D., an obstetrician-gynecologist who previously served as Georgia’s public health commissioner and president-elect of the Association of State and Territorial Health Officials, resigned today.
The Food and Drug Administration yesterday released a blueprint for educating health care providers that treat or monitor patients with pain.